𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen

✍ Scribed by Li-Min Huang; Bor-Luen Chiang; Chin-Yun Lee; Ping-Ing Lee; Wei-Kuang Chi; Mei-Hwei Chang


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
66 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Hepatitis B (HB) vaccine provides an uncertain duration of protection and the optimal timing of booster vaccine remains unclear. This study examined the immune response at 10 years of 118 children who had developed protective anti-HB surface (anti-HBs) levels after a primary series of HB immunizations in infancy. All of the children were born to hepatitis B e Antigen (HBeAg)-positive hepatitis B surface antigen (HBsAg) carrier mothers. HB markers in all subjects and cellular immune response in some were determined. A booster was given to all subjects after the collection of samples and another blood sample was collected 4 weeks later. The results showed that a total of 39 (33%) of the children were seronegative for anti-HBs. T-cell proliferative response to HBsAg was noted in 47% of children. On HBsAg stimulation, leukocyte samples from a significantly higher proportion of subjects produced cytokines (81% of T cells produced interleukin-2 [IL-2] and 100% produced IL-5). The booster dose of HB vaccine induced the production of a protective level of anti-HBs (H10 mIU/mL) in all subjects. Cellular immunity was augmented with a positive rate of 58%, 90%, and 100% for HBsAg-induced T-cell proliferation, IL-2 production, and IL-5 production, respectively. Although 14 (11.9%) of the subjects were HB core antibody positive at 10 years of age, no new HBsAg carrier was detected. The results of this study show that protection afforded by HB vaccination persisted to the age of 10 years in all vaccinees. Immunologic memory was detected in all subjects including those who had lost their anti-HBs seropositivity. These results suggest that no booster vaccination is needed before 10 years of age. The most sensitive marker of immunologic memory is IL-5 production of T cells. (HEPATOLOGY 1999;29: 954-959.


πŸ“œ SIMILAR VOLUMES


Humoral and cellular immune responses to
✍ H Hsu; M Chang; R Hsieh; Y Ni; W Chi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 1 views

Abbreviations: HBsAg, hepatitis B surface antigen; anti-HBs, hepatitis B surface antimonths. 2 From the 415 children, we recruited 16 chronically infected gen antibody; HBV, hepatitis B virus; PCR, polymerase chain reaction; PBMC, peripheral children who had cleared serum HBsAg for more than 2 years

Quantitative hepatitis B surface antigen
✍ Jung Min Lee; Sang Hoon Ahn; Hyon Suk Kim; Hana Park; Hye Young Chang; Do Young πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 384 KB πŸ‘ 1 views

Quantitative hepatitis B surface antigen (qHBsAg) and quantitative hepatitis B e antigen (qHBeAg) titers are emerging as useful tools for measuring viral loads and for predicting the virological response (VR) and serological response (SR) to pegylated interferon therapy. However, the clinical utilit

To define virological response in hepati
✍ Resat Ozaras; Hakan Leblebicioglu; Cafer Eroglu πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 1 views

Hou et al. compared the efficacies of telbivudine and lamivudine in patients with hepatitis B e antigen (HBeAg)-positive and HBeAg-negative chronic hepatitis B. 1 Virological response definition in the study (Ο½5 log 10 copies/mL) can not be applied to HBeAg-negative patients. HBeAg-negative patient

Very low dose hepatitis B vaccination in
✍ Dr. C. D. Moyes; A. Milne; J. Waldon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

## Abstract Seventy‐eight children who had received three very low doses (1 or 2 ΞΌg) of Merck, Sharp, and Dohme (MSD) plasma‐derived vaccine (PDV) in early infancy were followed to approximately four years of age. Of the 70 who had responded to the initial course of vaccine with measurable anti‐HBs